...a handful of liver diseases. 5AM Ventures and Wu Capital...
...$43 millionInvestors: Frazier Healthcare Partners, 5AM Ventures, Wu Capital...
...– Hydroxysteroid 17-beta dehydrogenase 13 Danielle Golovin Inipharm Inc. 5AM Ventures Wu Capital Frazier...

...$121 million already held by the SPAC. Existing shareholders OrbiMed Advisors, Atlas Venture, Lightstone and Wu Capital...

...to treat repeat expansion disorders, and was founding CEO of CRISPR company Intellia Therapeutics Inc. (NASDAQ:NTLA). Wu Capital...

...investors Eight Roads, F-Prime Capital and Vivo Capital were joined by 3H Health Investment and Wu Capital...

...Investments, EcoR1 Capital, Fidelity Management & Research Co., Polaris Founders Fund, Pagsgroup, Surveyor Capital and Wu Capital...

...are Canaan Partners, AbbVie Ventures, Casdin Capital, DROIA, Foresite Capital, Invus, Pontifax, Taiho Ventures and Wu Capital. Karen...

...Partners, AbbVie Ventures, Casdin Capital, DROIA Oncology Ventures, Foresite Capital, Invus, Pontifax, Taiho Ventures and Wu Capital...

...GV. Canaan Partners, AbbVie Ventures, Casdin Capital, DROIA, Foresite Capital, Invus, Pontifax, Taiho Ventures and Wu Capital...

...led the B round, which closed on Nov. 30. Fellow new investors ORI Healthcare Fund, Wu Capital...

...led by Eight Roads Ventures and Cowen Healthcare Investments. Fellow new investors ORI Healthcare Fund, Wu Capital...